Cargando…

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination

BACKGROUND: Immunotherapies have demonstrated clinical benefit for many types of cancers, however many patients do not respond, and treatment-related adverse effects can be severe. Hence many efforts are underway to identify treatment predictive biomarkers. We have reported the results of two phase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Laura E., Olson, Brian M., McNeel, Douglas G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514519/ https://www.ncbi.nlm.nih.gov/pubmed/28716080 http://dx.doi.org/10.1186/s40425-017-0260-3

Ejemplares similares

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines
por: Colluru, Viswa Teja, et al.
Publicado: (2016)

Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials
por: Olson, Brian M., et al.
Publicado: (2013)

His-tag ELISA for the detection of humoral tumor-specific immunity
por: Goodell, Vivian, et al.
Publicado: (2008)

Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
por: Rekoske, Brian, et al.
Publicado: (2013)

Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression
por: Jeon, Donghwan, et al.
Publicado: (2022)

Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response
por: Johnson, Laura E., et al.
Publicado: (2012)

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination
por: Becker, Jordan T, et al.
Publicado: (2013)

B lymphocyte mediated antigen presentation of plasmid DNA
por: Colluru, Viswa Teja, et al.
Publicado: (2013)

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
por: Smith, Heath A., et al.
Publicado: (2010)

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA
por: Rastogi, Ichwaku, et al.
Publicado: (2023)

Sipuleucel-T: immunotherapy for advanced prostate cancer
por: Olson, Brian M, et al.
Publicado: (2011)

Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer
por: McNeel, Douglas G., et al.
Publicado: (2018)

Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer
por: Muralidhar, Anusha, et al.
Publicado: (2023)

Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine
por: Wargowski, Ellen, et al.
Publicado: (2018)

Vaccines as treatments for prostate cancer
por: Rastogi, Ichwaku, et al.
Publicado: (2023)

Adjuvant DNA vaccine pNMM promotes enhanced specific immunity and anti-tumor effects
por: Wang, Yu, et al.
Publicado: (2023)

Tumor Associated Antigens and Their Specific Immune Response
por: Vose, B. M.
Publicado: (1980)

The Origin and Immune Recognition of Tumor-Specific Antigens
por: Apavaloaei, Anca, et al.
Publicado: (2020)

FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab
por: Scarpelli, Matthew, et al.
Publicado: (2019)

PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy
por: Zahm, Christopher D., et al.
Publicado: (2021)

Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
por: Das, Satya, et al.
Publicado: (2019)

Role of B cells as antigen presenting cells
por: Rastogi, Ichwaku, et al.
Publicado: (2022)

TCR diversity – a universal cancer immunotherapy biomarker?
por: McNeel, Douglas G.
Publicado: (2016)

Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
por: Gamat-Huber, Melissa, et al.
Publicado: (2020)

Enhanced specific immune responses by CpG DNA in mice immunized with recombinant hepatitis B surface antigen and HB vaccine
por: Zhang, Xiancheng, et al.
Publicado: (2011)

Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
por: Rosenbaum, Pierre, et al.
Publicado: (2021)

Improved generation of anti-tumor immunity by antigen dose limitation
por: Shofner, Joshua D, et al.
Publicado: (2007)

Cryoablation therapy stimulates the antigen-specific T cell immune responses generated by therapeutic HPV DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2015)

Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients
por: Palermo, Belinda, et al.
Publicado: (2018)

Long-Term Programming of Antigen-Specific Immunity from Gene Expression Signatures in the PBMC of Rhesus Macaques Immunized with an SIV DNA Vaccine
por: Belisle, Sarah E., et al.
Publicado: (2011)

Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses
por: Chen, Yu-Li, et al.
Publicado: (2012)

Whole-cell tumor vaccines desialylated to uncover tumor antigenic Gal/GalNAc epitopes elicit anti-tumor immunity
por: Huang, Jianmei, et al.
Publicado: (2022)

B7H6-specific chimeric antigen receptors lead to tumor elimination and host anti-tumor immunity
por: Wu, Ming-Ru, et al.
Publicado: (2015)

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles
por: Sullivan, Jeremy A., et al.
Publicado: (2020)

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
por: Ma, Leyuan, et al.
Publicado: (2023)

Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route
por: Carey, John B., et al.
Publicado: (2014)

Targeting and Specific Activation of Antigen‐Presenting Cells by Endogenous Antigen‐Loaded Nanoparticles Elicits Tumor‐Specific Immunity
por: Chang, Hao‐Cai, et al.
Publicado: (2019)

Recognition of immune-related tumor antigens and immune subtypes for mRNA vaccine development in lung adenocarcinoma
por: Zhao, Deze, et al.
Publicado: (2022)

IgG Responses to Tissue-Associated Antigens as Biomarkers of Immunological Treatment Efficacy
por: Smith, Heath A., et al.
Publicado: (2011)

In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination
por: Mao, Chih-Ping, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fk7cacigs4atrbmjuh1m2oqvnj